市場調查報告書
商品編碼
1577298
腸內飼管市場、機會、成長動力、產業趨勢分析與預測,2024-2032Enteral Feeding Tubes Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
受腸內餵食技術進步、慢性病患病率上升、人口老化、早產率上升以及家庭醫療保健採用趨勢不斷成長的推動,2024年至2032年全球腸內飼管市場將成長6.3%,除其他因素外。
推動腸內飼管產業成長的因素包括技術進步、人口老化和慢性病的增加。隨著醫療保健技術的發展,腸內餵食方法變得更加高效和方便用戶使用,從而導致越來越多的採用。全球慢性病的增加,尤其是人口老化,需要營養支持,進一步推動市場成長。此外,早產的激增和家庭醫療保健採用的成長趨勢凸顯了對腸內餵食解決方案的需求不斷擴大。
腸飼管市場根據產品、疾病狀況、病人、管類型、管放置、最終用途和地區進行分類。
市場將產品分為鼻腸/鼻飼管和腹部/造口飼管。鼻腸/鼻飼管段包括鼻胃管和鼻空腸管,而腹部/造口段包括胃造口管、空腸造口/空腸管和胃空腸管(GJ)或經空腸管。鼻腸/鼻飼管領域在 2023 年以 17 億美元的收入引領市場。這使它們成為各種臨床情況下臨時營養支持的理想選擇。此外,加護病房 (ICU) 中的患者通常無法口服進食,因此越來越依賴鼻腸飼管。這一趨勢是由重症疾病和手術導致的 ICU 入院率上升所推動的,凸顯了該細分市場的成長。
市場根據疾病狀況對腸內飼管進行分類,包括癌症、中樞神經系統 (CNS) 和心理健康問題、非惡性胃腸道 (GI) 疾病等。癌症細分市場進一步分為頭頸癌、胃腸道癌和其他癌症,到2023 年將佔48% 的腸內飼管市場佔有率。 。隨著癌症治療的進步提高了存活率,對長期營養支持的需求激增,推動了該領域的成長。
2023年北美腸內飼管市場規模達8.762億美元,預計2024年至2032年複合年成長率為5.9%。 。改進的飼管設計和高效的飼管等創新提高了採用率。此外,經常面臨先天畸形和嚴重疾病的兒科患者對腸內餵食的需求更高。這種針對弱勢兒科族群的特殊營養需求進一步推動了區域市場的成長。
The Global Enteral Feeding Tubes Market will witness a 6.3% from 2024 to 2032, driven by advancements in enteral feeding technology, a rising prevalence of chronic diseases, an aging population, an uptick in preterm births, and a growing trend towards home healthcare adoption, among other factors.
Factors driving the growth of the enteral feeding tubes industry include technological advancements, an aging population, and a rise in chronic diseases. As healthcare technology evolves, enteral feeding methods become more efficient and user-friendly, leading to increased adoption. The global rise in chronic diseases, especially in aging populations, necessitates nutritional support, further propelling market growth. Additionally, the surge in preterm births and the growing trend of home healthcare adoption underscore the expanding demand for enteral feeding solutions.
The Enteral Feeding Tubes Market is categorized based on product, disease condition, patient, tube type, tube placement, end use , and region.
The market categorizes products into nasoenteric/nasal feeding tubes and abdominal/ostomy feeding tubes. The nasoenteric/nasal feeding tube segment includes nasogastric and nasojejunal tubes, while the abdominal/ostomy segment encompasses gastrostomy, jejunostomy/jejunal, and gastrojejunal (GJ) or transjejunal tubes. The nasoenteric/nasal feeding tube segment led the market with a revenue of USD 1.7 billion in 2023. Nasoenteric tubes, favored for short-term feeding (typically under four weeks), are less invasive than other methods. This makes them ideal for temporary nutritional support across various clinical scenarios. Moreover, patients in intensive care units (ICUs), often unable to eat orally, increasingly rely on nasoenteric feeding tubes. This trend, driven by rising ICU admissions from critical illnesses and surgeries, underscores the segment's growth.
The market classifies enteral feeding tubes based on disease conditions, including cancer, central nervous system (CNS) & mental health issues, non-malignant gastrointestinal (GI) disorders, and others. The cancer segment, further divided into head and neck, gastrointestinal, and other cancers, commanded a 48% enteral feeding tubes market share in 2023. Treatments like chemotherapy and radiation can induce side effects such as nausea and difficulty swallowing. With advancements in cancer treatments boosting survival rates, the demand for long-term nutritional support has surged, propelling the segment's growth.
North America enteral feeding tubes market accounted for USD 876.2 million in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2032. As a frontrunner in healthcare innovation, North America has been pivotal in advancing enteral feeding technologies. Innovations, including enhanced feeding tube designs and efficient feeding pumps, have spurred adoption rates. Additionally, pediatric patients, often facing congenital abnormalities and severe illnesses, have a heightened need for enteral feeding. This specialized nutritional demand for vulnerable pediatric populations has further fueled the regional market growth.